Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03475875 · ClinicalTrials.gov registry record · Phase 2
Contact Lenses With New UV-blocker Manufactured With Different Techniques
A Phase 2 study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- Phase 2
- Development phase
- 92
- Enrollment target
NCT03475875 is a Phase 2 study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 92 participants.
The verdict
NCT03475875, a Phase 2 study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 92 participants
- Enrollment target
Study Summary
This study is a randomized, 4-visit, double-masked, 2x3 bilateral crossover, dispensing trial. The study lenses will be worn as daily wear (DW) for a period of two weeks each with one of the study lenses being worn twice. Each study lens is expected to be worn at least five (5) days per week for at least six (6) hours per day worn. There will be no washout period between study lenses.
Interventions
- DEVICE senofilcon A TEST Lens
- DEVICE senofilcon A CONTROL Lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2018-02-19 |
| Est. Completion | 2018-04-18 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03475875
The ClinicalTrials.gov registry entry for NCT03475875 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which senofilcon A TEST Lens is the first listed.
NCT03475875 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03475875 about?
NCT03475875 is a clinical study titled "Contact Lenses With New UV-blocker Manufactured With Different Techniques". This study is a randomized, 4-visit, double-masked, 2x3 bilateral crossover, dispensing trial. The study lenses will be worn as daily wear (DW) for a period of two weeks each with one of the study lenses being worn twice. Each study lens is expected to be worn at least five (5) days per week for at ...
What is the current status of trial NCT03475875?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 92 participants. The study started on 2018-02-19. Estimated completion is 2018-04-18.
What interventions are being tested in trial NCT03475875?
The interventions under investigation include: senofilcon A TEST Lens (DEVICE), senofilcon A CONTROL Lens (DEVICE).
Who is sponsoring clinical trial NCT03475875?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.